Portal Innovations

Closed
Call
Website
1375 W Fulton St Ste 650
Chicago, IL 60607
+1 (773) 498-5700
https://www.portalinnovations.com

Portal Innovations is a life sciences venture capital firm based in Chicago, IL, specializing in providing crafted capital to support early-stage biotech and medtech startups. Through a membership model, the firm grants access to state-of-the-art lab space and essential resources, fostering an environment conducive to innovation and growth.

With locations in Chicago, Atlanta, Boston, and Houston, Portal Innovations strategically positions its portfolio companies within vibrant work-live-play ecosystems. The firm combines financial support with management expertise, creating a comprehensive framework that empowers entrepreneurs to transform their ideas into impactful solutions in the life sciences sector.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Igenbio, Inc.

Igenbio, Inc. is a renowned leader in genome sequencing and analysis, based in Chicago. Specializing in cutting-edge technologies, Igenbio is at the forefront of providing innovative solutions for genetic research and bioinformatics. With a strong focus on precision and accuracy, Igenbio offers top-notch services that cater to the diverse needs of clients in the scientific community. Their expertise in genome analysis sets them apart as a trusted partner for advancing research and discovery. Generated from their website's infomation

Durata Therapeutics US Ltd

Durata Therapeutics US Ltd is a pharmaceutical company based in Chicago, IL that specializes in the development of innovative treatments for various medical conditions. With a focus on research and development, Durata Therapeutics US Ltd aims to improve patient outcomes and advance healthcare through cutting-edge therapies and technologies. Generated from their business information

Temprian Therapeutics Inc

Temprian Therapeutics is a developer of therapies intended for autoimmune disease. The company offers DNA-based treatment by injecting DNA coding for a modified heat shock protein to stop the autoimmune response at the outset, enabling consumers to get treatments for vitiligo disease.
United States›Illinois›Chicago›Portal Innovations

Partial Data by Infogroup (c) 2025. All rights reserved.